Fracture liaison and osteoporosis medication monitoring program at National Taiwan University Hospital
Official title: Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study in Rural Area
Run by National Taiwan University Hospital · NCT02635022 · Data updated 2026-11-12
This program tests whether a coordinated fracture liaison service plus a medication-monitoring service can help people aged 50+ with recent hip or spine fractures or on osteoporosis drugs stick with treatment and get appropriate follow-up.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Hsinchu) |
| Status | Recruiting |
| Started | September 2015 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | December 23, 2025 |
| Trial ID | NCT02635022 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People aged 50 or older with a new hip fracture, newly identified vertebral fracture, newly prescribed or changed anti-osteoporosis medication, poor adherence to AOMs, or whom clinicians believe would benefit from coordinated osteoporosis and medication management.
✕Probably not a fit
Patients with life expectancy under two years, atypical fractures, major communication barriers, participation in other medication trials, or who refuse assessments are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The program implemented a fracture liaison service (FLS) following the 13 'Capture the Fracture' best-practice standards and a complementary anti-osteoporosis medication (AOM) monitoring service at National Taiwan University Hospital. Eligible participants included patients aged 50 or older with a new hip fracture, newly identified radiographic or clinical vertebral fracture, newly prescribed or recently changed AOMs, or documented poor adherence. Participating physicians referred eligible patients to study coordinators who performed baseline assessments of fracture and osteoporosis risk, documented medical history and AOM use, and provided ongoing medication management and follow-up. The service aimed to close care gaps noted in regional data by improving testing, treatment initiation, and adherence over time.
Why it matters
Potential benefit: If successful, the program could increase osteoporosis testing and medication adherence and lower the risk of subsequent fractures.
How similar studies have gone: Other fracture liaison services that follow the Capture the Fracture standards have improved rates of bone density testing and osteoporosis treatment in multiple settings, though results on long-term fracture reduction are variable.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>=50 and one of the below * New hip fracture in orthopedic ward * Newly identified radiographic vertebral fractures from plan films in geriatric ward or clinical vertebral fractures in outpatient clinics * Newly prescribed with AOMs * Recent change of AOMs * Poor adherence to AOMs * Participating physicians feel that the service will benefit the patient in overall osteoporosis and medication managements. Exclusion Criteria: * Life expectancy less than 2 years or can't be assessed for communication problems * Atypical fractures * Patient in other medication clinical trials * Unwilling to accept the assessment and treatment
Where it's running
-
National Taiwan University Hospital, Chutung branch
Hsinchu, Taiwan Recruiting
Study contacts
- Principal investigator: Ding-Cheng Chan, MD, PhD — National Taiwan University Hospital, Chutung branch
- Study coordinator: Ding-Cheng Chan, MD, PhD
- Email: doctord6226@yahoo.com
- Phone: 886-2-23123456
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if a new tomosynthesis imaging tool helps diagnose MSK issues in ED and clinic
This study tests whether the Nanox.ARC Digital Tomosynthesis system can add diagnostic value for adults with suspected MSK problems and potentially reduce the need for CT or MRI.
-
REMS testing for osteoporosis diagnosis and fracture risk in adults compared with DXA
This study tests whether REMS can diagnose osteoporosis and predict fracture risk in adults who are being evaluated for bone health, using DXA as the standard reference.
-
Role of LH and hCG in adults being evaluated for endocrine disorders
This study looks at whether levels of luteinizing hormone (LH) and hCG in adults undergoing endocrine evaluation relate to their disease presence and outcomes.
-
Can a blood marker called lumican reveal hidden fragility in postmenopausal osteoporosis
This study tests whether serum lumican levels can help identify hidden fragility risk in postmenopausal women beyond what bone density shows.
-
Functional Muscle-Bone Incongruity Index: A look at muscle strength and bone health in adults
This observational study tests a composite FKUI score using handgrip strength and hip/spine bone density to see if it better reflects musculoskeletal health than each measure alone in adults undergoing routine DXA.
-
Vessel-X Bone Filling Container System for Vertebral Augmentation
A new minimally invasive vertebral augmentation approach tests the Vessel-X device to see if it safely improves pain and function in people with osteoporotic vertebral compression fractures.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.